Effectiveness of DMF (Dimethyl Fumarate) and Its Impact on PROs (Patient Reported Outcomes) in Treatment-Naive or Suboptimal IFN (Interferon) or GA (Glatiramer Acetate) Responders With RRMS (ImPROve)

Clinical trial NCT02323269 · TERMINATED

Trial details

NCT number: NCT02323269
Sponsor: Biogen
Status: TERMINATED
Study type: OBSERVATIONAL

Multiple Sclerosis, Relapsing-Remitting Relapsing-Remitting Multiple Sclerosis

Start date: 2015-05-01
Primary completion: 2016-03-01
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.